Vertex Pharmaceuticals Inc. buy Morgan Stanley
Start price
13.02.26
/
50%
€420.00
Target price
13.02.27
-
Performance (%)
8.64%
Price
12.08.26
€456.30
Summary
This prediction is currently active. With a performance of 8.64%, the BUY prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 13.02.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 8.656% | 8.656% |
| iShares Core DAX® | 0.184% | 5.072% |
| iShares Nasdaq 100 | -0.770% | -2.079% |
| iShares Nikkei 225® | 0.733% | -3.346% |
| iShares S&P 500 | -0.166% | 0.904% |
Comments by Morgan_Stanley for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€357.25
05.05.26
05.05.26
€527.05
05.05.27
05.05.27
27.73%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.55
10.04.26
10.04.26
€523.50
10.04.27
10.04.27
22.81%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€429.85
10.03.26
10.03.26
€512.68
10.03.27
10.03.27
6.15%
12.08.26
12.08.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€375.90
03.12.25
03.12.25
€443.40
03.12.26
03.12.26
21.39%
12.08.26
12.08.26